Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Smoking reduces plasma bilirubin: Observational and genetic analyses in the Copenhagen General Population Study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. Brief smoking cessation intervention in relation to breast cancer surgery: a randomized controlled trial

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Is there a health benefit of reduced tobacco consumption? A systematic review

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Obesity as a Causal Risk Factor for Aortic Valve Stenosis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Lipoprotein(a) Reduction in Persons with Cardiovascular Disease

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Body Mass Index, Triglycerides, and Risk of Acute Pancreatitis: A Population-Based Study of 118 000 Individuals

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Sedentary work and risk of venous thromboembolism

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Introduction: Observational studies have found lower concentrations of plasma bilirubin in current smokers compared to former and never smokers. However, whether there is a causal relationship between smoking and bilirubin is unknown. In a Mendelian randomisation analysis, we tested the hypothesis that higher tobacco consumption is causally associated with lower concentrations of plasma bilirubin.

Methods: We genotyped 103 557 individuals aged 20-100 years from the Copenhagen General Population Study for the CHRNA3 rs1051730 genotype, known to be associated with higher tobacco consumption. Tobacco consumption was defined as daily and cumulative tobacco consumption.

Results: In observational multivariable adjusted analyses, a 10 g/day higher daily tobacco consumption was associated with a 0.28 µmol/L (95% confidence interval: 0.20-0.35) lower concentration of plasma bilirubin in current smokers and a 10 pack-year higher cumulative smoking was associated with a 0.19 µmol/L (0.17-0.21) lower concentration of plasma bilirubin in former and current smokers. Using the CHRNA3 rs1051730 genotype as a proxy for daily and cumulative tobacco consumption, the difference in plasma bilirubin per T-allele was -0.12 µmol/L (-0.23 to -0.002) in current smokers and -0.09 µmol/L (-0.15 to -0.01) in current and former smokers combined. Furthermore, observationally bilirubin concentrations increased with time from smoking cessation in former smokers.

Conclusion: Higher daily and cumulative tobacco consumption were associated with lower concentrations of plasma bilirubin in observational and genetic analyses, suggesting that the association is causal.

OriginalsprogEngelsk
TidsskriftNicotine & Tobacco Research
Sider (fra-til)104-110
ISSN1462-2203
DOI
StatusUdgivet - jan. 2020

ID: 56612675